A more accurate and noninvasive look at cancerous tumors

July 10, 2012 by Christina Cavanaugh

(Medical Xpress) -- Chao Zhou believes his work with combining imaging technologies has the potential to improve surgeries that remove malignant breast tumors.

“As many as 40 percent of breast cancer patients now have to undergo a second surgery, because part of the tumor is left behind during the first,” says Zhou, an assistant professor of electrical and computer engineering.

By combining two technologies—optical coherence tomography (OCT) and confocal microscopy—Zhou says doctors can more precisely pinpoint a tumor’s location and remove it entirely on the first try.

One advantage of this hybrid approach, he says, is that it allows tissue to be imaged without being damaged or removed from the body. Tissue suspected of being cancerous is now typically removed, sectioned and stained—a technique known as histopathology—before it can be examined.

The combination of OCT and confocal microscopy can also provide information about embryonic forms without requiring samples to be removed from organisms.

Imaging in real time

OCT enables 3-D tissue imaging based on recognition and analysis of the light-scattering patterns caused by internal structures. Confocal microscopy, a form of optical microscopy, produces high-resolution but cannot penetrate tissue as deeply. Optical coherence microscopy (OCM) combines the two and increases resolution and imaging depth by compiling only coherent light, which is in focus.

“The goal of my research is to provide in situ, real-time imaging of tissue microstructures with a resolution approaching that of histopathology,” says Zhou, who is affiliated with Lehigh’s bioengineering program.

Before joining the faculty in June, Zhou was a senior postdoctoral associate at the Massachusetts Institute of Technology, where he pioneered the use of OCT in cancer detection.

He received a Pathway to Independence research award in 2011 from the National Institute of Biomedical Imaging and Bioengineering in the National Institutes of Health.

Until now, says Zhou, doctors have evaluated tumor margin by taking a frozen section or histopathology. These techniques do not provide instant results.

OCT, by contrast, achieves real-time imaging. By combining OCT and OCM, Zhou can alternate between high and low magnifications when viewing the same fresh, unsliced tissue samples. He has been able to identify clusters of cancerous cells within a larger sample based on the tissue’s appearance under a microscope.

“We’re also using OCT and OCM to look at developmental biology,” Zhou said. “In current practice, if you want to examine a developing embryo or animal, you have to sacrifice it and cut it up. Our goal is to be able to image embryonic structures in a less destructive way.

“We can image [interior cross-sections of] the systolic and diastolic rhythms of an embryonic fly’s heart, and compare a normal heart to one with cardio-arrhythmia,” Zhou said. Because the heart rhythm is being imaged, it is vital that the organism be living; this can be accomplished with OCT. Zhou plans to extend his imaging of embryonic forms to other organisms.

“OCT, when combined with OCM, can get in vivo, 3-D structural and functional images without needing to remove and process tissues,” Zhou says. “OCT and OCM allow us to lay the foundations for providing real-time information in surgical suites and the pathology lab.”

Explore further: Girls' verbal skills make them better at arithmetic

Related Stories

Girls' verbal skills make them better at arithmetic

February 23, 2012
(PhysOrg.com) -- While boys generally do better than girls in science and math, some studies have found that girls do better in arithmetic. A new study published in Psychological Science, a journal of the Association for ...

New high-speed 3-D imaging system holds potential for improved cancer screening

August 1, 2011
Researchers at the Massachusetts Institute of Technology (MIT) have developed a new imaging system that enables high-speed, three-dimensional (3-D) imaging of microscopic pre-cancerous changes in the esophagus or colon. The ...

New endoscope technology paves the way for 'molecular-guided surgery' for cancer

March 27, 2012
(PhysOrg.com) -- With more than 15 million endoscope procedures done on patients each year in the U.S. alone, scientists today reported evidence that a new version of these flexible instruments for diagnosing and treating ...

Recommended for you

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.